Research output per year
Research output per year
Personal profile
Research interests
I conduct clinical trials focused on the treatment and prognosis of patients with leukemias and lymphomas and patients undergoing stem cell transplantation. In addition, my group has established a lymphoma tissue bank for the collection of tumor, blood, bone marrow, and germline tissue from patients with non-Hodgkin and Hodgkin lymphoma. The specimens in the lymphoma tumor bank will be used for the study of clinical, genetic, and immunologic parameters that have prognostic significance and/or are involved in the initiation and progression of lymphoma.
Clinical interests
Oncology, stem cell transplant, CAR T-cell therapy, lymphoma, leukemia, myelodysplastic syndromes.
Fingerprint
Dive into the research topics where Amanda Cashen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Abboud, R., Schroeder, M. A., Rettig, M. P., Jayasinghe, R. G., Gao, F., Eisele, J., Gehrs, L., Ritchey, J., Choi, J., Abboud, C. N., Pusic, I., Jacoby, M., Westervelt, P., Christopher, M., Cashen, A., Ghobadi, A., Stockerl-Goldstein, K., Uy, G. L. & DiPersio, J. F., Mar 27 2025, In: Blood. 145, 13, p. 1382-1394 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response: EARLY PHASE STUDIES
Jacoby, M. A., Duncavage, E. D., Khanna, A., Chang, G. S., Nonavinkere Srivatsan, S., Miller, C. A., Gao, F., Robinson, J., Shao, J., Fulton, R. S., Fronick, C. C., O’Laughlin, M., Heath, S. E., Brendel, K., Chavez, M., DiPersio, J. F., Abboud, C. N., Stockerl-Goldstein, K., Westervelt, P. & Cashen, A. & 7 others, , Jan 2025, In: Leukemia. 39, 1, p. 166-177 12 p.Research output: Contribution to journal › Article › peer-review
-
Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912
Shanafelt, T. D., Wang, X. V., Hanson, C. A., Paietta, E., O’Brien, S., Barrientos, J., Jelinek, D. F., Braggio, E., Leis, J. F., Zhang, C. C., Barr, P. M., Cashen, A. F., Mato, A. R., Singh, A. K., Mullane, M. P., Little, R. F., Erba, H., Stone, R. M., Litzow, M. & Tallman, M. & 1 others, , Jan 14 2025, In: Blood Advances. 9, 1, p. 224-228 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies
Desai, P., Lonial, S., Cashen, A., Kamdar, M., Flinn, I., O'Brien, S., Garcia, J. S., Korde, N., Moslehi, J., Wey, M., Cheung, P., Sharma, S., Olabode, D., Chen, H., Syed, F. A., Liu, M., Saeh, J., Andrade-Campos, M., Kadia, T. M. & Blachly, J. S., Nov 1 2024, In: Clinical Cancer Research. 30, 21, p. 4844-4855 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations